JD Health International Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	31,785	22,629	15,037	18,718	17,252
Short-Term Investments	14,687	18,169	16,799	27,951	23,637
Trading Asset Securities	501.37	10,438	9,385	1,003	1,101
Cash & Short-Term Investments	46,973	51,236	41,221	47,672	41,990
Cash Growth	-8.32%	24.29%	-13.53%	13.53%	4.18%
Accounts Receivable	436.3	857.92	706.76	1,301	405.68
Other Receivables	-	289.04	265.35	686.59	53.75
Receivables	436.3	1,147	972.1	1,988	459.43
Inventory	6,858	5,843	5,085	5,996	3,041
Prepaid Expenses	-	20.72	16.35	15.79	14.03
Restricted Cash	7.74	32.66	15.38	33	25.35
Other Current Assets	2,074	181.73	540.23	742.43	175.35
Total Current Assets	56,349	58,460	47,850	56,447	45,705
Property, Plant & Equipment	1,230	795.99	288	251.91	260.78
Long-Term Investments	21,644	9,584	13,197	1,523	1,031
Other Intangible Assets	1,933	2,095	2,182	2,268	25.39
Long-Term Deferred Tax Assets	399.23	312.93	299.83	208.47	95.86
Other Long-Term Assets	31.43	26.89	471.77	578.98	883.8
Total Assets	81,587	71,275	64,288	61,277	48,002
Accounts Payable	13,210	12,484	11,340	11,143	5,710
Accrued Expenses	6,175	391.88	305.78	1,204	180.82
Current Portion of Leases	206.64	109.67	95.32	70.65	67.55
Current Income Taxes Payable	598.27	207.1	337.54	380.19	118.81
Current Unearned Revenue	552.31	537.92	405.6	1,375	395.41
Other Current Liabilities	-	1,791	2,100	2,184	1,532
Total Current Liabilities	20,741	15,521	14,585	16,356	8,005
Long-Term Leases	429.38	148.72	119.43	128.76	133.72
Long-Term Deferred Tax Liabilities	342.61	364.41	213.61	7.82	8.89
Total Liabilities	21,513	16,034	14,918	16,493	8,148
Common Stock	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	-	59,977	58,551	57,063	56,242
Retained Earnings	-7,971	-13,224	-17,336	-19,382	-19,715
Treasury Stock	-34.54	-60.73	-92.57	-34.3	-50.64
Comprehensive Income & Other	68,078	8,539	8,233	7,134	3,377
Total Common Equity	60,072	55,231	49,356	44,780	39,853
Minority Interest	1.39	9.68	14.51	4.31	1.19
Shareholders' Equity	60,073	55,241	49,370	44,785	39,855
Total Liabilities & Equity	81,587	71,275	64,288	61,277	48,002
Total Debt	636.02	258.39	214.75	199.41	201.27
Net Cash (Debt)	46,337	50,977	41,007	47,473	41,789
Net Cash Growth	-9.10%	24.32%	-13.62%	13.60%	3.92%
Net Cash Per Share	14.50	16.13	12.96	15.10	13.50
Filing Date Shares Outstanding	3,167	3,146	3,127	3,106	3,098
Total Common Shares Outstanding	3,167	3,146	3,127	3,106	3,098
Working Capital	35,607	42,939	33,265	40,091	37,700
Book Value Per Share	18.97	17.56	15.78	14.42	12.86
Tangible Book Value	58,139	53,137	47,174	42,512	39,828
Tangible Book Value Per Share	18.36	16.89	15.08	13.69	12.86

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.